Anesthetic drugs & techniques

Nasal continuous positive pressure versus simple face mask oxygenation for adult obese and obstructive sleep apnea patients undergoing colonoscopy under propofol-based general anesthesia without tracheal intubation: A randomized controlled trial

J Clin AnesthPublished Randomised controlled trial

An erratum to this article was published (J Clin Anesth, Oct 2024 ↗)

Authors' conclusion

A nasal CPAP did not prevent hypoxemia and should not be used routinely for colonoscopy in obese or OSA patients if a simple face mask is an alternative therapy.

Study context

Population
Obese and/or OSA adults undergoing colonoscopy under propofol GA without planned tracheal intubation, tertiary academic centre6 had a hypoxemic event
Participants
109 adults
Comparison
Nasal CPAP mask vs simple face mask for supplementary O2 at 10 L/min
  • Nasal CPAPn = 55
  • Simple face maskn = 54reference
Primary endpoint
Difference in mean percentage of time with oxygen saturation below 90%
Methodological detailssingle-centre, prospective
  • Single-centre
  • Prospective

Primary result

As reported in the abstract

Percentage of time with oxygen saturation below 90%
  • Difference not clinically relevant among patients with a hypoxemic event
  • Nasal CPAP vs Simple face mask: P = 1.0

Secondary outcomes

Chin lift required

P = 0.01

Oral cannula insertion

P = 0.03

At least one airway maneuver

P = 0.005

OutcomeNasal CPAPSimple face maskP value
Patient tolerance to device scoreLower in the nasal CPAP group8.859.56P = 0.003

Original publication

Nasal continuous positive pressure versus simple face mask oxygenation for adult obese and obstructive sleep apnea patients undergoing colonoscopy under propofol-based general anesthesia without tracheal intubation: A randomized controlled trial. J Clin Anesth. Published 3 July 2023. doi:10.1016/j.jclinane.2023.111196

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.